Archive for: M+ Check Up

  • ORIGINAL ANALYSIS

  • PDF DOWNLOAD

  • EXTERNAL LINK

  • POST

Insight: original analysis

McDermottPlus Check-Up: November 15, 2019

Government funding negotiations continued against the backdrop of impeachment, and the CMS issued new rules on provider price transparency and Medicaid supplemental payments.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: November 8, 2019

There was little activity in Congress with the House in recess, but we saw several developments in the Medicaid space including new guidance from the CMS.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: November 1, 2019

This Week’s Dose: Drug pricing discussions continued in Congress. The full House and the Senate Health, Education, Labor, and Pensions (HELP) Committee advanced health bills.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: September 20, 2019

This Week’s Dose: Speaker Pelosi released her long-awaited drug pricing bill, and the House Energy and Commerce Committee questioned drug companies’ financial motivations during a hearing this week.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: August 2, 2019

This Week’s Dose: Things have quieted down in Congress with the House out of session and the Senate wrapping up its last week before the August recess. But the agencies are still at work, so don’t totally check out just yet.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: July 26, 2019

This Week’s Dose: The Senate Finance Committee finally released its drug pricing package and moved quickly to a markup. The bill passed out of committee, but work will continue before the full Senate votes. We’ll be watching closely as things develop.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: July 19, 2019

This Week’s Dose: The Energy and Commerce Committee held a marathon mark-up of 25 bills, including 10 health care related bills. The No Surprises Act received an amendment that adds arbitration to the payment dispute process. The House voted to repeal the Cadillac tax. And, we finally have a Congressional Budget Office (CBO) score for…

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: July 12, 2019

This Week’s Dose: Congress is back for the final legislative session before the August recess, and it’s all about what can get done ahead of the break. House and Senate committees have already advanced a cost containment legislation that includes surprise billing and prescription drug cost provisions, among many other things. We still await any…

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: June 28, 2019

This Week’s Dose: Lots of movement in Congress ahead of the Fourth of July recess with the House and Senate both advancing a number of health care bills. President Trump also signed an executive order this week, continuing the Administration’s focus on health care transparency.

POST

Insight: original analysis

McDermottPlus Check-Up: June 21, 2019

This Week’s Dose: Three weeks down, one week to go in this work period. The Senate Health, Education, Labor and Pensions (HELP) Committee is moving forward with its cost containment legislation, and the House passed the first batch of health care extenders.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: June 14, 2019

This Week’s Dose: The focus was back on surprise billing this week with the third hearing of the year. We also saw hearings on Medicare for All and vertical consolidation in the health care industry, and the House advanced an appropriations package.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: June 7, 2019

This Week’s Dose: Congress is back, and this week marked the start of another busy legislative session. Work continues on drug pricing, surprise billing and cost containment, and negotiations have begun on an extenders package as well.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: May 10, 2019

This Week’s Dose: Another busy week for prescription drug pricing. Two more hearings took place on the subject, and a handful of bills passed out of the House. Now we watch the Senate to see how it packages and advances prescription drug bills that have moved through the House.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: May 3, 2019

This Week’s Dose: Lots of activity surrounding single-payer this week with a hearing, the introduction of two Medicare expansion bills and a report from the Congressional Budget Office (CBO). Hearings and markups of drug pricing bills continue as well. This legislative session is off to a busy start.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: April 26, 2019

This Week’s Dose: When Congress is away, the agencies will play. The Administration made some major announcements and dropped several new important rules this week, giving stakeholders plenty to talk about (and work on) while Congress is in recess.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: April 12, 2019

This Week’s Dose: Drug pricing continues to be the focus in Congress with multiple hearings and markups on the subject. So far, lowering drug prices remains a rare area of consensus among lawmakers.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: April 5, 2019

This Week’s Dose: Health care continues to dominate much of the attention on Capitol Hill. Lots of hearings. New coverage expansion legislation. And more state action on Medicaid.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: March 8, 2019

This Week’s Diagnosis: Hearings, hearings and more hearings. FDA Commissioner Scott Gottlieb is stepping down. Budget talks heat up.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: February 22, 2019

This Week’s Diagnosis: It’s all quiet on the Hill. Members return Monday after the first full week of district work time in the 116th Congress.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: February 15, 2019

This Week’s Diagnosis: Congress passed a $328 billion spending package to avert another government shutdown.  President Trump is expected to sign it.  Congressional hearings continue to focus on coverage and drug pricing.  

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: February 8, 2019

This Week’s Dose: The State of the Union briefly highlighted a few Administration health initiatives. The House continues its focus on the Affordable Care Act (ACA). The Senate is pressuring CEOs from the largest drug manufacturers to testify.  

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: February 1, 2019

This Week’s Diagnosis: Government reopens…for at least three weeks. Congress is full steam ahead, kicking off the 116th with health care hearings on drug pricing and pre-existing conditions. The US Department of Health and Human Services focuses on 2019 priorities.

ORIGINAL ANALYSIS

Insight: original analysis

McDermott Plus Check-up: January 25, 2019

This Week’s Diagnosis: Hearings are beginning and priorities are emerging. The shutdown drags on. And updates are trickling out of the Administration.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: January 18, 2019

This Week’s Diagnoses: Shutdown enters historic territory. Prescription drug costs emerge as a priority issue for the 116th Congress. Committee assignments are almost complete.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: January 11, 2019

This Week’s Diagnosis: Welcome back – sort of. The partial federal government shutdown drags on. We are on day 21 with no end in sight, which has shifted the focus of the new Congress away from overarching health priorities and toward continued efforts to reopen the government.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: December 21, 2018

This Week’s Diagnosis: Time is ticking for any deal to avoid any partial government shutdown. It is the only thing holding up adjournment.

POST

Insight: original analysis

McDermottPlus Check-Up: December 14, 2018

This Week’s Diagnosis: President Trump clashed with House Democratic Leader Nancy Pelosi (D-CA) and Senate Minority Leader Chuck Schumer (D-NY) in a meeting this week about how to keep the government’s lights on. The President threatened to shut down the government on December 21, when the current short-term funding agreement expires, if his request for…

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: December 7, 2018

This Week’s Diagnosis: Memorial services for President George H.W. Bush were held this week in Washington, DC and Texas. No agreement has been reached on border wall funding, which means Members may be here through at least December 21.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: November 30, 2018

This Week’s Diagnoses: Welcome back! Members are back in town for a sprint to the finish. Controversy over the House Democratic leadership elections fizzled, with the same faces in the top three positions.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: November 16, 2018

This Week’s Diagnosis: Newly elected congressional members were welcomed to Washington this week, while currently serving members returned for a brief, but important post-election lame duck session.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: November 9, 2018

This Week’s Diagnoses: Was the election only four days ago? Tuesday brought change to Congress. While a handful of races have yet to be called, Democrats will take charge of the House of Representatives, while Republicans will retain control of the Senate come January 2019. We have a full breakdown of what the election results…

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: November 2, 2018

This Week’s Diagnosis: While members of Congress are touting the passage of the opioid package on the campaign trail, the Administration continued releasing a series of significant health policy regulations.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: October 26, 2018

This Week’s Diagnosis: The Administration remains active with the issuance of several new guidance documents, the drug pricing announcement and the President (finally) signing the bipartisan opioid legislation (HR 6).

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: October 19, 2018

This Week’s Diagnoses: All eyes are on the midterm election, now less than three weeks away.  The House and Senate are out; the Administration continues to release health-related regulations and announcements.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: October 12, 2018

With midterms less than one month away, it is relatively quiet around Washington, DC. The Senate completed its work on Thursday and now joins the House in recess until after the midterm elections.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: October 5, 2018

This Week’s Diagnosis: The Senate continues to chug along with hearings, opioids and judicial nominees. All is quiet in DC on the House side – members are in their home districts campaigning for re-election.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: September 28, 2018

This Week’s Diagnosis: Consideration of the Kavanaugh nomination dominated airtime in the Senate this week, but the House stayed on-task, pushing through a number of health-related bills.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: September 21, 2018

This Week’s Diagnosis: The Senate was working in full force this week. The House is back next week for what is rumored to be the last session week until the election.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-up: September 14, 2018

McDermott+Consulting is pleased to introduce the McDermottPlus Check-up, your regular update on healthcare policy from Washington, D.C.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-up: September 7, 2018

McDermott+Consulting is pleased to introduce the McDermottPlus Check-up, your regular update on healthcare policy from Washington, D.C.

ORIGINAL ANALYSIS

Load more
beakernav X1E2BFA62-BFCE-43C1-B777-27E3E5216018medical bagoriginal analysis +external linkpdf downloadstethoscope